z-logo
open-access-imgOpen Access
YEAR RESULTS OF EJECTION FRACTION IN PATIENTS WITH ACUTE CORONARY SYNDROME AFER MULTIVESSEL PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY
Author(s) -
Firdovsi İbrahimov
Publication year - 2019
Publication title -
evrazijskij kardiologičeskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2305-0748
pISSN - 2225-1685
DOI - 10.38109/2225-1685-2019-2-46-53
Subject(s) - medicine , acute coronary syndrome , ejection fraction , cardiology , percutaneous transluminal coronary angioplasty , revascularization , coronary angiography , angioplasty , randomized controlled trial , myocardial infarction , heart failure
Aim . The aim of this randomized clinic trial was to study 5-year follow up of morbidity and mortality in patients with acute coronary syndrome after conducted multivessel percutaneous transluminal coronary angioplasty (PTCA). Material and methods . The trial was carried out in two groups with EF 35% for assessment of acute coronary syndrome impact to myocardial revascularization. 742 patients were included to the trial. All patients were undergone coronary angiography admitted during 6 hours after MI and followed through PTCA. 5 year follow-up of morbidity was investigated on these patients considering an initial EF. Results. 129 patients had got EF indices lower than 35%. Only 122 patients (94%) among these ones completed the 5 year follow up. 613 patients had got EF with initial indices higher than 35%. Average age of patients with EF 35% - 55,8 year (SD 10-17). 110 patients (90,2%) with EF 35% were men. 12 (9,8%) women were in the group with EF35%. Only 577 (93,8%) of them completed the follow up. The estimation of morbidity and mortality were done in divided groups by EF for both sex. Also there were investigated and compared the causes of death in both groups. Conclusion . EF was determined as an important factor influenced morbidity and mortality in patients after PTCA.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here